What is Pitney Bowes Inc.'s earnings per share (EPS)?

Pitney Bowes Inc. (PBI) reported diluted earnings per share of $0.84 for fiscal year 2025. This represents a 175.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Pitney Bowes Inc. (PBI) Financials

PBI

Trailing 12 months to June 30, 2026

Revenue $1.9B -5.3% YoY

Net Income $187.3M +269.6% YoY

EPS (Diluted) $1.23 +305.0% YoY

Free Cash Flow $415.2M +141.3% YoY

Market Cap $2.3B as of Oct 10, 2026

Price / Sales 1.2x on $1.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 12.3x on $187.3M net income, trailing 12 months to June 30, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PBI SEC filings page.

Pitney Bowes Inc. (PBI) reported $1.9B in revenue over the twelve months to Jun 30, 2026, down 5.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PBI FY2025 2026-10-03

The business is converting a shrinking sales base into cash, but capital returns continue despite a structurally thin balance sheet.

Cash generation improved before capitalization did: operating cash flow reached $383M in FY2025 while net income was $145M, so cash production substantially exceeded reported earnings. Yet liabilities exceeded assets by $802M, and $378M of buybacks sent cash outward, leaving the recovery concentrated in cash flow rather than balance-sheet strength.

Revenue declined to $1.9B in FY2025, but free cash flow reached $317M; this is a cash-generative contraction, not a growth story. SG&A fell to $622M from $718M in FY2024, indicating cost reduction accompanied the smaller sales base.

Operating cash flow rose to $383M from $229M, showing the cash improvement was not limited to the reported profit line. The 0.7x current ratio and buybacks indicate tighter near-term resources even as capital was returned to shareholders.

Financial Health Signals

Financial Health Score 16/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Pitney Bowes Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Pitney Bowes Inc., and counted as zero in the overall score.

Growth

Pitney Bowes Inc.'s revenue declined 6.6% year-over-year, from $2.0B to $1.9B. This contraction results in a growth score of 17/100.

Leverage

Liquidity

Pitney Bowes Inc.'s current ratio of 0.71 is below the typical benchmark, resulting in a score of 8/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Pitney Bowes Inc. converts 16.8% of revenue into free cash flow ($317.0M). This strong cash generation earns a score of 68/100.

Returns

Not available for Pitney Bowes Inc., and counted as zero in the overall score.

Piotroski F-Score Partial

6/8

Pitney Bowes Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.65x

For every $1 of reported earnings, Pitney Bowes Inc. generates $2.65 in operating cash flow ($383.3M OCF vs $144.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$451.5M

YoY-2.3%

QoQ-5.4%

Pitney Bowes Inc. generated $451.5M in revenue in Q2 2026. This represents a decrease of 2.3% from the same quarter a year earlier. Against the prior quarter it is down 5.4%.

Net Income

$49.9M

YoY+66.5%

QoQ-14.2%

Pitney Bowes Inc. reported $49.9M in net income in Q2 2026. This represents an increase of 66.5% from the same quarter a year earlier. Against the prior quarter it is down 14.2%.

EPS (Diluted)

$0.36

YoY+111.8%

QoQ-7.7%

5Y CAGR+26.8%

10Y CAGR+2.5%

Pitney Bowes Inc. earned $0.36 per diluted share (EPS) in Q2 2026. This represents an increase of 111.8% from the same quarter a year earlier. Against the prior quarter it is down 7.7%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$134.4M

YoY+37.1%

QoQ+374.9%

5Y CAGR+28.5%

10Y CAGR+7.6%

Pitney Bowes Inc. generated $134.4M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 37.1% from the same quarter a year earlier. Against the prior quarter it is up 374.9%.

Cash & Debt

$266.8M

YoY-6.4%

QoQ-11.9%

5Y CAGR-19.7%

10Y CAGR-8.7%

Pitney Bowes Inc. held $266.8M in cash against $2.0B in long-term debt as of Q2 2026.

Dividends Per Share

$0.10

YoY+42.9%

QoQ+11.1%

5Y CAGR+14.9%

10Y CAGR-6.1%

Pitney Bowes Inc. paid $0.10 per share in dividends in Q2 2026. This represents an increase of 42.9% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

Shares Outstanding

137M

YoY-20.4%

QoQ+1.2%

5Y CAGR-4.9%

10Y CAGR-3.0%

Pitney Bowes Inc. had 137M shares outstanding in Q2 2026. This represents a decrease of 20.4% from the same quarter a year earlier. Against the prior quarter it is up 1.2%.

Margins & Returns

Net Margin

11.1%

YoY+4.6pp

QoQ-1.1pp

Pitney Bowes Inc.'s net profit margin was 11.1% in Q2 2026, showing the share of revenue converted to profit. This is up 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$3.4M

YoY-6.1%

QoQ-10.8%

Pitney Bowes Inc. invested $3.4M in research and development in Q2 2026. This represents a decrease of 6.1% from the same quarter a year earlier. Against the prior quarter it is down 10.8%.

Share Buybacks

$52.8M

YoY-29.9%

QoQ-61.1%

10Y CAGR-2.3%

Pitney Bowes Inc. spent $52.8M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 29.9% from the same quarter a year earlier. Against the prior quarter it is down 61.1%.

Capital Expenditures

$18.5M

YoY+38.5%

QoQ+16.7%

5Y CAGR-14.5%

10Y CAGR-4.9%

Pitney Bowes Inc. invested $18.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 38.5% from the same quarter a year earlier. Against the prior quarter it is up 16.7%.

PBI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PBI quarterly income statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.9B	$1.9B-6.6%	$2.0B-2.5%	$2.1B-16.3%	$2.5B-32.4%	$3.7B+3.4%	$3.6B+10.9%	$3.2B-0.2%	$3.2B+15.4%	$2.8B-6.6%	$3.0B-16.7%	$3.6B-6.4%	$3.8B+0.8%	$3.8B-0.8%	$3.8B-5.1%	$4.0B
Cost of Revenue	N/A	N/A	$964.3M-8.0%	$1.0B	N/A	$2.6B+6.1%	$2.4B+25.1%	$1.9B+7.4%	$1.8B+25.0%	$1.4B-5.4%	$1.5B-2.8%	$1.6B-7.3%	$1.7B+1.8%	$1.7B+4.3%	$1.6B	N/A
Gross Profit	N/A	N/A	$1.1B+3.1%	$1.0B	N/A	$1.1B-2.4%	$1.1B-10.4%	$1.3B-9.7%	$1.4B+5.2%	$1.4B-7.9%	$1.5B-27.4%	$2.0B-5.7%	$2.1B0.0%	$2.1B-4.5%	$2.2B	N/A
R&D Expenses	$14.1M	$15.3M-52.2%	$32.0M+8.4%	$29.5M-16.9%	$35.5M-24.2%	$46.8M+21.9%	$38.4M-25.1%	$51.3M-12.4%	$58.5M-3.8%	$60.9M-43.3%	$107.4M-2.5%	$110.2M+0.2%	$109.9M-0.4%	$110.4M-3.4%	$114.3M-11.5%	$129.2M
SG&A Expenses	$547.2M	$621.6M-13.4%	$717.9M-8.2%	$781.6M-0.5%	$785.5M-15.0%	$924.2M-4.1%	$963.3M-4.1%	$1.0B+0.1%	$1.0B-2.6%	$1.0B-9.7%	$1.1B-10.9%	$1.3B-7.1%	$1.4B-2.9%	$1.4B-4.7%	$1.5B-5.4%	$1.6B
Interest Expense	-$106.8M	-$101.5M-192.2%	$110.1M+9.6%	$100.4M+11.6%	$90.0M-7.1%	$96.9M-8.4%	$105.8M-4.6%	$110.9M-3.9%	$115.4M-2.2%	$118.0M+32.6%	$89.0M+1.6%	$87.6M-3.6%	$90.9M-16.8%	$109.3M-5.2%	$115.2M-0.1%	$115.4M
Income Tax	$65.1M	$47.8M+130.9%	-$154.8M-992.5%	$17.3M-59.6%	$43.0M+493.3%	-$10.9M-253.4%	$7.1M+154.3%	-$13.1M-304.6%	$6.4M-53.0%	$13.7M-87.2%	$107.0M-43.6%	$189.8M+68.2%	$112.8M+44.7%	$78.0M-31.8%	$114.3M+304.2%	$28.3M
Net Income	$187.3M	$144.7M+171.1%	-$203.6M+47.2%	-$385.6M-1143.9%	$36.9M+2834.3%	-$1.4M+99.3%	-$180.4M-192.8%	$194.3M-19.6%	$241.8M-0.7%	$243.5M+162.4%	$92.8M-77.3%	$407.9M+22.2%	$333.8M+133.7%	$142.8M-67.9%	$445.2M-27.9%	$617.5M
EPS (Basic)	N/A	$0.84+174.3%	-$1.13+48.6%	-$2.20-1147.6%	$0.21+2200.0%	-$0.01+99.0%	-$1.05-195.5%	$1.10-14.7%	$1.29-1.5%	$1.31+167.3%	$0.49-76.0%	$2.04+23.6%	$1.65+132.4%	$0.71-68.0%	$2.22-27.5%	$3.06
EPS (Diluted)	$1.23	$0.84+175.0%	-$1.12+49.1%	-$2.20-1147.6%	$0.21+2200.0%	-$0.01+99.0%	-$1.05-195.5%	$1.10-14.1%	$1.28-1.5%	$1.30+165.3%	$0.49-75.9%	$2.03+23.8%	$1.64+134.3%	$0.70-68.3%	$2.21-27.5%	$3.05
Diluted Shares (Avg)	N/A	173M-5.2%	183M+3.9%	176M-0.9%	177M-1.0%	179M+4.4%	172M-3.3%	177M-5.8%	188M+0.5%	187M-0.8%	189M-6.0%	201M-1.5%	204M+0.5%	203M+0.8%	201M-0.7%	203M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$451.5M-2.3%	$477.4M-3.2%	$477.6M-7.5%	$459.7M-8.0%	$461.9M-5.7%	$493.4M-5.3%	$516.1M-2.0%	$499.5M-0.7%
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$238.5M-7.8%	$238.0M-4.0%
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$277.6M+3.6%	$261.5M+2.5%
R&D Expenses	$3.4M-6.1%	$3.8M-20.3%	$3.5M	$3.4M-55.0%	$3.6M-50.4%	$4.8M-37.5%	N/A	$7.6M-1.7%
SG&A Expenses	$128.7M-24.5%	$133.4M-19.6%	$141.0M	$144.2M-24.1%	$170.5M-11.5%	$165.9M-11.2%	N/A	$190.0M+4.0%
Interest Expense	-$28.6M-14.6%	-$26.0M-7.1%	-$26.2M	-$26.1M-193.9%	-$24.9M-186.7%	-$24.3M-187.4%	N/A	$27.8M+3.7%
Income Tax	$15.6M+67.6%	$22.3M+97.5%	$11.0M+280.0%	$16.2M+109.7%	$9.3M+309.3%	$11.3M-27.0%	-$6.1M-523.4%	-$166.5M-1926.3%
Net Income	$49.9M+66.5%	$58.1M+64.1%	$27.3M+173.1%	$52.0M+137.5%	$30.0M+220.5%	$35.4M+1327.8%	-$37.4M+83.3%	-$138.5M-1006.1%
EPS (Basic)	$0.37+117.6%	$0.40+110.5%	$0.18+185.7%	$0.31+140.3%	$0.17+221.4%	$0.19+1050.0%	-$0.21+83.5%	-$0.77-1000.0%
EPS (Diluted)	$0.36+111.8%	$0.39+105.3%	$0.18+185.7%	$0.30+140.0%	$0.17+221.4%	$0.19+1050.0%	-$0.21+83.5%	-$0.75-971.4%
Diluted Shares (Avg)	139M-23.2%	148M-20.0%	N/A	170M-7.3%	181M+1.3%	185M+1.8%	N/A	184M+1.9%

Not reported in any period shown, so not listed: Operating Income, EBITDA.

PBI Balance Sheet

PBI quarterly balance sheet

Metric	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.2B-6.7%	$3.4B-20.5%	$4.3B-9.9%	$4.7B-4.4%	$5.0B-5.1%	$5.2B-4.5%	$5.5B-7.9%	$5.9B-10.5%	$6.6B+13.7%	$5.8B-4.7%	$6.1B-5.5%	$6.5B-4.4%	$6.8B-13.8%	$7.9B-3.5%	$8.1B
Current Assets	$1.1B-16.5%	$1.3B-36.0%	$2.1B+14.5%	$1.8B-5.0%	$1.9B-10.4%	$2.1B-5.5%	$2.2B-17.1%	$2.7B-4.7%	$2.8B+21.7%	$2.3B0.0%	$2.3B-15.9%	$2.8B-2.6%	$2.8B-11.6%	$3.2B-1.5%	$3.3B
Cash & Equivalents	$284.9M-39.4%	$469.7M-21.7%	$600.1M-10.2%	$668.3M-8.8%	$732.5M-20.5%	$921.5M-0.3%	$924.4M+6.6%	$867.3M-14.0%	$1.0B+32.0%	$764.5M+19.4%	$640.2M-38.6%	$1.0B+18.5%	$880.7M-2.3%	$901.8M+5.3%	$856.2M
Short-Term Investments	$12.2M-25.3%	$16.4M-26.1%	$22.2M+98.4%	$11.2M-22.6%	$14.4M-23.9%	$19.0M-83.6%	$115.9M+95.1%	$59.4M+21.2%	$49.0M+27.4%	$38.4M-69.8%	$127.4M+113.0%	$59.8M+14.7%	$52.1M+42.4%	$36.6M+182.3%	$13.0M
Inventory	$66.2M+10.7%	$59.8M-5.1%	$63.0M-24.7%	$83.7M+6.5%	$78.6M+9.9%	$71.5M+4.7%	$68.3M+9.6%	$62.3M+52.8%	$40.8M-56.0%	$92.7M+4.4%	$88.8M+4.7%	$84.8M-18.1%	$103.6M-42.4%	$179.7M+0.6%	$178.6M
Accounts Receivable	$168.1M+5.1%	$160.0M-20.1%	$200.2M-41.7%	$343.6M+2.7%	$334.6M-14.0%	$389.2M+4.2%	$373.5M+0.5%	$371.8M-12.9%	$427.0M-6.3%	$455.5M-4.4%	$476.6M+9.0%	$437.3M-6.9%	$469.8M-35.5%	$728.3M+0.6%	$723.6M
Long-Term Investments	$166.6M+8.1%	$154.1M-38.4%	$250.2M-3.7%	$260.0M-21.9%	$333.1M-8.6%	$364.2M+52.5%	$238.9M-23.3%	$311.4M-28.5%	$435.6M+2.3%	$425.7M+3.2%	$412.4M+24.0%	$332.5M+13.3%	$293.5M	$0	$0
Goodwill	$746.7M+3.6%	$721.0M-1.8%	$734.4M-13.7%	$851.3M-25.0%	$1.1B-1.5%	$1.2B-13.0%	$1.3B-0.6%	$1.3B-0.1%	$1.3B-4.7%	$1.4B-19.8%	$1.7B+4.4%	$1.7B-3.6%	$1.7B-18.8%	$2.1B-0.5%	$2.1B
Total Liabilities	$4.0B-0.1%	$4.0B-14.3%	$4.6B-0.9%	$4.7B-3.4%	$4.8B-6.0%	$5.2B-0.5%	$5.2B-11.2%	$5.8B-10.2%	$6.5B+9.4%	$5.9B+5.2%	$5.6B-7.8%	$6.1B-2.3%	$6.3B-15.7%	$7.4B-5.7%	$7.9B
Current Liabilities	$1.5B-7.5%	$1.7B-11.9%	$1.9B+9.9%	$1.7B0.0%	$1.7B-7.6%	$1.9B+19.2%	$1.6B-16.9%	$1.9B-8.7%	$2.1B-11.1%	$2.3B+2.1%	$2.3B-1.6%	$2.3B+3.9%	$2.2B-22.6%	$2.9B-6.9%	$3.1B
Non-Current Liabilities	$2.4B+5.2%	$2.3B-16.0%	$2.7B-7.1%	$3.0B-5.3%	$3.1B-5.0%	$3.3B-9.1%	$3.6B-8.5%	$3.9B-10.9%	$4.4B+22.6%	$3.6B+7.2%	$3.4B-11.6%	$3.8B-5.8%	$4.0B-11.3%	$4.6B-5.0%	$4.8B
Long-Term Debt	$2.0B+5.9%	$1.9B-10.6%	$2.1B-3.9%	$2.2B-5.5%	$2.3B-2.1%	$2.3B-13.7%	$2.7B-11.3%	$3.1B-13.9%	$3.6B+29.4%	$2.8B+10.5%	$2.5B-14.9%	$2.9B-12.5%	$3.3B-8.1%	$3.6B-1.1%	$3.7B
Total Equity	-$802.4M-38.7%	-$578.4M-56.9%	-$368.6M-707.7%	$60.7M-46.1%	$112.6M+59.5%	$70.6M-75.6%	$289.2M+183.9%	$101.8M+233.3%	$30.6M+129.5%	-$103.7M-158.0%	$178.7M+131.3%	$77.3M-62.3%	$205.2M+61.0%	$127.4M+673.6%	-$22.2M
Retained Earnings	$2.7B-0.6%	$2.7B-13.2%	$3.1B-39.9%	$5.1B-0.8%	$5.2B-0.7%	$5.2B-4.3%	$5.4B+3.0%	$5.3B+1.0%	$5.2B+2.4%	$5.1B-0.9%	$5.2B+5.3%	$4.9B+3.9%	$4.7B-1.0%	$4.8B+3.5%	$4.6B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.0B-6.8%	$3.1B-3.7%	$3.2B-6.7%	$3.3B-10.8%	$3.2B-20.6%	$3.3B-20.3%	$3.4B-20.5%	$3.6B-17.5%
Current Assets	$1.0B-7.6%	$1.1B-4.7%	$1.1B-16.5%	$1.1B-22.6%	$1.1B-29.9%	$1.2B-25.1%	$1.3B-36.0%	$1.5B-8.1%
Cash & Equivalents	$266.8M-6.4%	$302.9M-6.5%	$284.9M-39.4%	$321.0M-42.8%	$285.2M-51.7%	$323.8M-37.3%	$469.7M-21.7%	$561.5M+0.7%
Short-Term Investments	$11.9M-23.6%	$11.1M-31.1%	$12.2M-25.3%	$15.0M+7.2%	$15.6M-28.6%	$16.2M-26.0%	$16.4M-26.1%	$14.0M-35.7%
Inventory	$62.9M-20.4%	$62.6M-3.8%	$66.2M+10.7%	$75.7M+5.7%	$79.0M+3.3%	$65.1M-17.3%	$59.8M-5.1%	$71.6M-14.5%
Accounts Receivable	$147.9M-4.8%	$158.6M-1.1%	$168.1M+5.1%	$161.7M-14.4%	$155.3M-41.6%	$160.3M-47.8%	$160.0M-20.1%	$188.8M-34.6%
Long-Term Investments	$162.5M+10.9%	$164.2M	$166.6M+8.1%	$167.3M	$146.6M	$0	$154.1M-38.4%	$0
Goodwill	$740.4M-1.1%	$742.9M+1.8%	$746.7M+3.6%	$746.5M+1.3%	$748.5M+2.9%	$729.7M+0.1%	$721.0M-1.8%	$737.3M-22.0%
Total Liabilities	$3.9B+2.8%	$4.0B+6.2%	$4.0B-0.1%	$3.9B-6.0%	$3.8B-16.2%	$3.8B-15.3%	$4.0B-14.3%	$4.2B-8.4%
Current Liabilities	$1.4B-4.8%	$1.8B+22.1%	$1.5B-7.5%	$1.4B-15.6%	$1.5B-11.3%	$1.5B-8.4%	$1.7B-11.9%	$1.7B+2.7%
Non-Current Liabilities	$2.5B+7.8%	$2.2B-4.1%	$2.4B+5.2%	$2.5B+0.5%	$2.3B-19.1%	$2.3B-19.3%	$2.3B-16.0%	$2.5B-14.6%
Long-Term Debt	$2.0B+6.9%	$1.8B-6.6%	$2.0B+5.9%	$2.1B+1.7%	$1.9B-8.9%	$1.9B-8.5%	$1.9B-10.6%	$2.1B-2.3%
Total Equity	-$863.3M-60.8%	-$893.6M-66.7%	-$802.4M-38.7%	-$661.5M-27.5%	-$536.8M-25.5%	-$535.9M-36.6%	-$578.4M-56.9%	-$518.9M-314.7%
Retained Earnings	$2.7B+1.1%	$2.7B+1.4%	$2.7B-0.6%	$2.7B-3.3%	$2.7B-9.5%	$2.7B-12.4%	$2.7B-13.2%	$2.7B-43.6%

PBI Cash Flow Statement

PBI quarterly cash flow statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$485.6M	$383.3M+67.2%	$229.2M+186.1%	$80.1M-54.2%	$175.0M-41.9%	$301.5M-0.2%	$302.0M+12.7%	$267.9M-22.3%	$344.7M-24.1%	$454.2M-8.5%	$496.1M-5.1%	$523.0M-20.6%	$658.3M+5.4%	$624.8M-5.4%	$660.2M-30.4%	$949.0M
Depreciation & Amortization	N/A	$111.6M-2.5%	$114.5M+1.6%	$112.7M+1.4%	$111.2M-31.7%	$162.9M+1.4%	$160.6M+0.9%	$159.1M+7.2%	$148.5M+17.1%	$126.8M-27.2%	$174.1M+0.4%	$173.3M-12.5%	$198.1M-6.2%	$211.2M-17.3%	$255.6M-0.7%	$257.5M
Stock-Based Compensation	N/A	$14.2M-14.4%	$16.5M+86.6%	$8.9M-45.7%	$16.3M-21.8%	$20.9M+19.4%	$17.5M-24.5%	$23.1M+10.0%	$21.0M-13.7%	$24.4M+63.9%	$14.9M-29.3%	$21.0M+20.7%	$17.4M+16.9%	$14.9M-18.1%	$18.2M-2.5%	$18.7M
Capital Expenditures	$70.4M	$66.3M-8.5%	$72.4M-7.3%	$78.1M-5.5%	$82.6M-55.1%	$184.0M+75.3%	$105.0M-23.5%	$137.3M-0.4%	$137.8M+16.5%	$118.2M-25.7%	$159.2M-4.5%	$166.7M-9.0%	$183.3M+33.3%	$137.5M-22.1%	$176.6M+13.2%	$156.0M
Free Cash Flow	$415.2M	$317.0M+102.2%	$156.8M+7809.5%	$2.0M-97.9%	$92.4M-21.3%	$117.5M-40.4%	$197.0M+50.8%	$130.6M-36.8%	$206.8M-38.4%	$335.9M-0.3%	$336.9M-5.4%	$356.2M-25.0%	$475.0M-2.5%	$487.3M+0.8%	$483.6M-39.0%	$793.0M
Investing Cash Flow	-$77.7M	-$125.1M-155.0%	-$49.1M+60.5%	-$124.1M-411.3%	-$24.3M+84.4%	-$155.3M-105.1%	-$75.7M-116.5%	$457.6M+59.8%	$286.3M+146.1%	-$621.4M-437.7%	-$115.6M+61.9%	-$303.2M-96.0%	-$154.7M-164.1%	$241.2M+378.0%	-$86.7M+26.1%	-$117.4M
Financing Cash Flow	-$424.4M	-$445.4M-45.8%	-$305.5M-918.1%	-$30.0M+84.9%	-$198.1M+40.0%	-$330.4M-40.4%	-$235.4M+64.9%	-$670.3M+10.1%	-$745.4M-302.7%	$367.7M+260.2%	-$229.5M+60.3%	-$578.7M-85.6%	-$311.8M+64.1%	-$868.1M-67.1%	-$519.6M-14.2%	-$455.0M
Dividends Paid	$54.3M	$51.1M+42.0%	$36.0M+2.1%	$35.2M+1.4%	$34.7M-0.2%	$34.8M+1.5%	$34.3M-3.0%	$35.4M-74.8%	$140.5M+0.7%	$139.5M-0.8%	$140.6M-6.3%	$150.1M-1.0%	$151.6M-19.7%	$188.8M-37.2%	$300.6M+0.3%	$299.6M
Share Buybacks	$476.5M	$378.4M	$0	$0-100.0%	$13.4M	$0	$0-100.0%	$105.0M	$0	$0-100.0%	$197.3M+49.8%	$131.7M+163.4%	$50.0M	$0	$0-100.0%	$100.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$152.9M+37.3%	$44.2M+364.7%	$221.7M+64.9%	$66.8M+353.3%	$111.4M+20.3%	-$16.7M-32.3%	$134.5M+43.1%	$14.7M-43.0%
Depreciation & Amortization	$23.7M-17.6%	$25.6M-9.5%	$27.1M-5.3%	$27.4M-4.0%	$28.8M+1.0%	$28.3M-1.8%	$28.6M+1.3%	$28.6M+503.9%
Stock-Based Compensation	N/A	$3.3M+22.2%	N/A	N/A	N/A	$2.7M+24.6%	N/A	N/A
Capital Expenditures	$18.5M+38.5%	$15.8M-6.2%	$20.3M-8.7%	$15.8M-18.7%	$13.3M-19.0%	$16.9M+17.9%	$22.2M-20.4%	$19.4M+339.8%
Free Cash Flow	$134.4M+37.1%	$28.3M+184.3%	$201.4M+79.4%	$51.1M+1188.0%	$98.0M+28.9%	-$33.6M-24.7%	$112.3M+69.8%	-$4.7M-121.9%
Investing Cash Flow	-$17.4M+39.0%	-$9.3M+79.6%	-$14.6M-184.2%	-$36.4M+5.7%	-$28.6M-80.0%	-$45.5M-284.6%	$17.3M+160.3%	-$38.6M-11.2%
Financing Cash Flow	-$171.1M-38.6%	-$16.4M+80.7%	-$243.0M-2.3%	$6.1M+184.6%	-$123.4M-5099.1%	-$85.1M-45.6%	-$237.4M-749.7%	-$7.2M-123.7%
Dividends Paid	$13.6M+7.5%	$13.3M+21.3%	$14.2M+55.4%	$13.3M+46.8%	$12.6M+41.0%	$11.0M+24.3%	$9.1M+2.5%	$9.1M+2.9%
Share Buybacks	$52.8M-29.9%	$135.6M+804.3%	$126.6M	$161.5M	$75.3M	$15.0M	$0	$0

PBI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PBI quarterly financial ratios

Metric	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	52.4%+2.9pp	49.6%	N/A	30.5%-1.8pp	32.3%-7.7pp	40.0%-4.2pp	44.3%-4.3pp	48.5%-0.7pp	49.2%-7.3pp	56.4%+0.4pp	56.0%-0.4pp	56.5%-2.2pp	58.6%	N/A
Net Margin	7.6%+17.7pp	-10.1%+8.5pp	-18.6%-20.0pp	1.5%+1.5pp	0.0%+5.0pp	-5.1%-11.1pp	6.1%-1.5pp	7.5%-1.2pp	8.8%+5.6pp	3.1%-8.3pp	11.4%+2.7pp	8.7%+5.0pp	3.8%-7.9pp	11.6%-3.7pp	15.3%
Return on Equity	N/A	N/A	N/A	60.9%+62.1pp	-1.2%+254.2pp	-255.4%-322.6pp	67.2%-170.2pp	237.4%-559.6pp	797.1%	N/A	228.3%-203.7pp	432.0%+362.4pp	69.6%-279.8pp	349.4%	N/A
Return on Assets	4.6%+10.6pp	-6.0%+3.0pp	-9.0%-9.8pp	0.8%+0.8pp	0.0%+3.4pp	-3.5%-7.0pp	3.5%-0.5pp	4.1%+0.4pp	3.7%+2.1pp	1.6%-5.1pp	6.7%+1.5pp	5.1%+3.0pp	2.1%-3.5pp	5.7%-1.9pp	7.6%
Current Ratio	0.71-0.1x	0.79-0.3x	1.080.0x	1.04-0.1x	1.090.0x	1.13-0.3x	1.420.0x	1.43+0.1x	1.37+0.4x	1.000.0x	1.02-0.2x	1.19-0.1x	1.27+0.2x	1.12+0.1x	1.05
Debt-to-Equity	N/A	N/A	N/A	35.82+15.4x	20.41-12.8x	33.25+23.8x	9.41-20.7x	30.11-86.4x	116.50	N/A	13.93-24.0x	37.89+21.6x	16.31-12.3x	28.59	N/A
Asset Turnover	0.600.0x	0.60+0.1x	0.490.0x	0.52-0.2x	0.74+0.1x	0.68+0.1x	0.590.0x	0.54+0.1x	0.42-0.1x	0.51-0.1x	0.580.0x	0.590.0x	0.56+0.1x	0.490.0x	0.49
FCF Margin	16.8%+9.0pp	7.7%+7.6pp	0.1%-3.6pp	3.7%+0.5pp	3.2%-2.3pp	5.5%+1.5pp	4.1%-2.4pp	6.4%-5.6pp	12.1%+0.8pp	11.3%+1.3pp	10.0%-2.5pp	12.4%-0.4pp	12.8%+0.2pp	12.7%-7.0pp	19.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	53.8%+2.9pp	52.3%+1.7pp
Net Margin	11.1%+4.6pp	12.2%+5.0pp	5.7%+13.0pp	11.3%+39.0pp	6.5%+11.6pp	7.2%+7.7pp	-7.2%+35.3pp	-27.7%-25.2pp
Return on Assets	1.7%+0.7pp	1.8%+0.8pp	0.9%+2.0pp	1.6%+5.4pp	0.9%+1.5pp	1.1%+1.1pp	-1.1%+4.1pp	-3.8%-3.5pp
Current Ratio	0.730.0x	0.62-0.2x	0.71-0.1x	0.81-0.1x	0.76-0.2x	0.80-0.2x	0.79-0.3x	0.88-0.1x
Asset Turnover	0.150.0x	0.150.0x	0.150.0x	0.140.0x	0.140.0x	0.150.0x	0.150.0x	0.140.0x
FCF Margin	29.8%+8.5pp	5.9%+12.7pp	42.2%+20.4pp	11.1%+12.1pp	21.2%+5.7pp	-6.8%-1.6pp	21.8%+9.2pp	-0.9%-5.2pp

Not reported in any period shown, so not listed: Operating Margin, Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$802.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.71), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Pitney Bowes Inc. PBI	FY2025	$1.9B	$144.7M	7.6%	$2.3B	16/100
HUB Group Inc HUBG	FY2024	$3.9B	$104.0M	2.6%	$1.6B	47/100
Forward Air Corp FWRD	FY2025	$2.5B	-$104.0M	-4.2%	$528.3M	30/100
Radiant Logistics, Inc. RLGT	FY2026	$934.4M	$18.8M	2.0%	$431.9M	48/100
CryoPort, Inc. CYRX	FY2025	$176.2M	$78.3M	44.4%	$878.8M	53/100
GXO Logistics, Inc. GXO	FY2025	$13.2B	$36.0M	0.3%	$5.3B	42/100

Where Pitney Bowes Inc. Ranks

Frequently Asked Questions

What is Pitney Bowes Inc.'s annual revenue?

Pitney Bowes Inc. (PBI) reported $1.9B in total revenue for fiscal year 2025. This represents a -6.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Pitney Bowes Inc.'s revenue growing?

Pitney Bowes Inc. (PBI) revenue declined by 6.6% year-over-year, from $2.0B to $1.9B in fiscal year 2025.

Is Pitney Bowes Inc. profitable?

Yes, Pitney Bowes Inc. (PBI) reported a net income of $144.7M in fiscal year 2025, with a net profit margin of 7.6%.

How much debt does Pitney Bowes Inc. have?

As of fiscal year 2025, Pitney Bowes Inc. (PBI) had $284.9M in cash and equivalents against $2.0B in long-term debt.

What is Pitney Bowes Inc.'s net profit margin?

Pitney Bowes Inc. (PBI) had a net profit margin of 7.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Pitney Bowes Inc. pay dividends?

Yes, Pitney Bowes Inc. (PBI) paid $0.30 per share in dividends during fiscal year 2025.

What is Pitney Bowes Inc.'s free cash flow?

Pitney Bowes Inc. (PBI) generated $317.0M in free cash flow during fiscal year 2025. This represents a 102.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Pitney Bowes Inc.'s operating cash flow?

Pitney Bowes Inc. (PBI) generated $383.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Pitney Bowes Inc.'s total assets?

Pitney Bowes Inc. (PBI) had $3.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Pitney Bowes Inc.'s capital expenditures?

Pitney Bowes Inc. (PBI) invested $66.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Pitney Bowes Inc. spend on research and development?

Pitney Bowes Inc. (PBI) invested $15.3M in research and development during fiscal year 2025.

Does Pitney Bowes Inc. buy back shares?

Yes, Pitney Bowes Inc. (PBI) spent $378.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Pitney Bowes Inc. have outstanding?

Pitney Bowes Inc. (PBI) had 150M shares outstanding as of fiscal year 2025.

What is Pitney Bowes Inc.'s current ratio?

Pitney Bowes Inc. (PBI) had a current ratio of 0.71 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Pitney Bowes Inc.'s return on assets (ROA)?

Pitney Bowes Inc. (PBI) had a return on assets of 4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Pitney Bowes Inc.'s P/E ratio?

Pitney Bowes Inc. (PBI) trades at 12.3x earnings, its market capitalization divided by net income of $187.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Pitney Bowes Inc.'s price-to-sales ratio?

Pitney Bowes Inc. (PBI) trades at 1.2x sales, its market capitalization divided by revenue of $1.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is Pitney Bowes Inc.'s debt-to-equity ratio negative or not reported?

Pitney Bowes Inc. (PBI) has negative shareholder equity of -$802.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Pitney Bowes Inc.'s Piotroski F-Score?

Pitney Bowes Inc. (PBI) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Pitney Bowes Inc.'s earnings high quality?

Pitney Bowes Inc. (PBI) has an earnings quality ratio of 2.65x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Pitney Bowes Inc.?

Pitney Bowes Inc. (PBI) scores 16 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.